Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: A systematic review and meta-analysis

World Journal of Gastroenterology

Volumn 11, Issue 17, 2005, Pages 2656-2661

  Ding, Xiang ^a   Yang, Lian Yue ^a   Huang, Geng Wen ^a   Yang, Jian Qing ^a   Liu, He Li ^a   Wang, Wei ^a   Peng, Ji Xiang ^a   Yang, Jie Quan ^a   Tao, Yi Ming ^a   Chang, Zhi Gang ^a   Ling, Xiu Shou ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

AFP nRNA; HCC; Meta analysis

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER RECURRENCE; CLINICAL TRIAL; CORRELATION ANALYSIS; DATA ANALYSIS; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LIVER CELL CARCINOMA; MEDICAL INFORMATION; META ANALYSIS; METHODOLOGY; ONLINE SYSTEM; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUBLICATION; SCORING SYSTEM; SYSTEMATIC REVIEW;

EID: 21044439174     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i17.2656     Document Type: Article

References (32)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-543
2. Yang LY, Huang GW. Surgical strategy of large hepatocellular carcinoma. Linchuang Waike Zazhi 2001; 9: 4-5
3. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-507
4. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418-1425
5. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214-2219
6. Blendis L, Wong F. A marker for predictions of HCC recurrence postresection? Gasteroentrology 2002; 123: 2152-2153
7. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 2001; 18: 705-719
8. Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002; 87: 694-701
9. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Jones DR, Heney D, Burchill SA. Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer 2003; 88: 1191-1198
10. Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999; 5: 4021-4027
11. Wong IH, Lau WY, Leung T, Johnson PJ. Quantitative comparison of alpha-fetoprotein and Albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000; 156: 141-149
12. Wong IH, Yeo W, Leung T, Lau WY, Johnson PJ. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 2001; 167: 183-191
13. Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, Bismuth H, Debuire B. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 1997; 226: 43-50
14. Okuda N, Nakao A, Takeda S, Oshima K, Kanazumi N, Nonami T, Kurokawa T, Takagi H. Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC. Hepatogastroenterology 1999; 46: 381-386
15. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564-568
16. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. Alpha-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860
17. Minata M, Nishida N, Komeda T, Azechi H, Katsuma H, Nishimura T, Kuno M, Ito T, Yamamoto Y, Ikai I, Yamaoka Y, Fukuda Y, Nakao K. Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol 2001; 16: 445-451
18. Witzigmann H, Geissler F, Benedix F, Thiery J, Uhlmann D, Tannapfel A, Wittekind C, Hauss J. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131: 34-43
19. Matsumura M, Shiratori Y, Niwa Y, Tanaka T, Ogura K, Okudaira T, Imamura M, Okano K, Shiina S, Omata M. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol 1999; 31: 332-339
20. Liu Y, Zhang BH, Qian GX, Chen H, Wu MC, Fu JL, Huang CH. The change of peripheral blood AFP mRNA expression in patients with recurrent HCC. Zhonghua Shiyan Waike Zazhi 1999; 16: 571
21. Liu Y, Zhang BH, Qian GX, Chen H, Wu MC. The relationship between hematogenous dissemination of tumor cells and postoperative relapse or distant metastasis in patients with hepatocellular carcinoma. Zhonghua Putong Waike Zazhi 1999; 14: 171-172
22. Wu XF, Fan J, Lin ZY, Wu ZQ, Lu JZ, Zhou J, Tang ZY. Quantitative analysis of AFP mRNA in portal, hepatic and peripheral venous blood of patients with HCC during liver surgery and its clinical significance. Zhonghua Gandan Waike Zazhi 2003; 9: 338-341
23. Hu CJ, Yang DL, Wang BC, Liu RQ. The role of AFP mRNA in detecting micrometastasis of hepatocellular carcinoma. Zhonghua Xiaohua Zazhi 1998; 18: 182-183
24. Yuan YH, Hu PJ. The clinical significance of detection of hepatocellular specific AFP mRNA in peripheral venous blood from patients with hepatocellular carcinoma. Zhongshan Yike Daxue Xuebao 2002; 21: 144-147.
25. Zhang J, Cheng KL, Kou LY. Detection of hepatocellular carcinoma cells in peripheral blood of patients with HCC. Shiyong Aizheng Zazhi 1998; 13: 257-259
26. Zhou JX, Yang XS, Yuan AL, Lai ZS. Influence of peripheral blood disseminating tumor cells in patients with hepatocellular carcinoma performed by surgical resection and TAE and prospective assess the value of AFP mRNA for prognosis. Linchuang Xiaohuabing Zazhi 2000; 12: 207-208
27. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234: 63-70
28. Louha M, Nicolet J, Zylberberg H, Sabile A, Vons C, Vona G, Poussin K, Tournebize M, Capron F, Pol S, Franco D, Lacour B, Brechot C, Paterlini-Brechot P. Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 1999; 29: 879-882
29. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989; 86: 2617-2621
30. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997; 350: 326-329
31. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001; 1: 5
32. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-484